Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

Condition:   Pulmonary Sarcoidosis Interventions:   Drug: Efzofitimod 3 mg/kg;   Drug: Efzofitimod 5 mg/kg;   Drug: Placebo Sponsors:   aTyr Pharma, Inc.;   Kyorin Pharmaceutical Co.,Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials